ATE295735T1 - Verwendung von interleukin-6 antagonisten zur behandlung von oestrogen-abhängigen krebs - Google Patents

Verwendung von interleukin-6 antagonisten zur behandlung von oestrogen-abhängigen krebs

Info

Publication number
ATE295735T1
ATE295735T1 AT00911250T AT00911250T ATE295735T1 AT E295735 T1 ATE295735 T1 AT E295735T1 AT 00911250 T AT00911250 T AT 00911250T AT 00911250 T AT00911250 T AT 00911250T AT E295735 T1 ATE295735 T1 AT E295735T1
Authority
AT
Austria
Prior art keywords
antagonists
interleukin
dependent cancer
treat estrogen
estrogen
Prior art date
Application number
AT00911250T
Other languages
English (en)
Inventor
Michael John Reed
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE295735T1 publication Critical patent/ATE295735T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT00911250T 2000-03-06 2000-03-06 Verwendung von interleukin-6 antagonisten zur behandlung von oestrogen-abhängigen krebs ATE295735T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2000/000072 WO2001066131A1 (en) 2000-03-06 2000-03-06 Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase

Publications (1)

Publication Number Publication Date
ATE295735T1 true ATE295735T1 (de) 2005-06-15

Family

ID=11133493

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00911250T ATE295735T1 (de) 2000-03-06 2000-03-06 Verwendung von interleukin-6 antagonisten zur behandlung von oestrogen-abhängigen krebs

Country Status (17)

Country Link
US (1) US7160860B2 (de)
EP (1) EP1261367B1 (de)
JP (1) JP2003525906A (de)
KR (1) KR100694005B1 (de)
AT (1) ATE295735T1 (de)
AU (1) AU2000233235A1 (de)
CA (1) CA2400711A1 (de)
CZ (1) CZ20022760A3 (de)
DE (1) DE60020269T2 (de)
DK (1) DK1261367T3 (de)
ES (1) ES2241583T3 (de)
HU (1) HUP0300117A3 (de)
MX (1) MXPA02008697A (de)
PL (1) PL356846A1 (de)
PT (1) PT1261367E (de)
SK (1) SK12412002A3 (de)
WO (1) WO2001066131A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6793678B2 (en) 2002-06-27 2004-09-21 Depuy Acromed, Inc. Prosthetic intervertebral motion disc having dampening
US8105382B2 (en) 2006-12-07 2012-01-31 Interventional Spine, Inc. Intervertebral implant
US8900307B2 (en) 2007-06-26 2014-12-02 DePuy Synthes Products, LLC Highly lordosed fusion cage
AU2009205896A1 (en) 2008-01-17 2009-07-23 Synthes Gmbh An expandable intervertebral implant and associated method of manufacturing the same
BRPI0910325A8 (pt) 2008-04-05 2019-01-29 Synthes Gmbh implante intervertebral expansível
US9526620B2 (en) 2009-03-30 2016-12-27 DePuy Synthes Products, Inc. Zero profile spinal fusion cage
US9393129B2 (en) 2009-12-10 2016-07-19 DePuy Synthes Products, Inc. Bellows-like expandable interbody fusion cage
US9763678B2 (en) 2010-06-24 2017-09-19 DePuy Synthes Products, Inc. Multi-segment lateral cage adapted to flex substantially in the coronal plane
US8979860B2 (en) 2010-06-24 2015-03-17 DePuy Synthes Products. LLC Enhanced cage insertion device
AU2011271465B2 (en) 2010-06-29 2015-03-19 Synthes Gmbh Distractible intervertebral implant
US9402732B2 (en) 2010-10-11 2016-08-02 DePuy Synthes Products, Inc. Expandable interspinous process spacer implant
US8394129B2 (en) 2011-03-10 2013-03-12 Interventional Spine, Inc. Method and apparatus for minimally invasive insertion of intervertebral implants
US8518087B2 (en) 2011-03-10 2013-08-27 Interventional Spine, Inc. Method and apparatus for minimally invasive insertion of intervertebral implants
WO2014018098A1 (en) 2012-07-26 2014-01-30 DePuy Synthes Products, LLC Expandable implant
US9717601B2 (en) 2013-02-28 2017-08-01 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9522070B2 (en) 2013-03-07 2016-12-20 Interventional Spine, Inc. Intervertebral implant
US11426290B2 (en) 2015-03-06 2022-08-30 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9913727B2 (en) 2015-07-02 2018-03-13 Medos International Sarl Expandable implant
JP6995789B2 (ja) 2016-06-28 2022-01-17 イーアイティー・エマージング・インプラント・テクノロジーズ・ゲーエムベーハー 拡張可能かつ角度調節可能な椎間ケージ
CN109640889B (zh) 2016-06-28 2021-07-30 Eit 新兴移植技术股份有限公司 可扩张的角度可调节式关节运动椎间保持架
US10537436B2 (en) 2016-11-01 2020-01-21 DePuy Synthes Products, Inc. Curved expandable cage
US10888433B2 (en) 2016-12-14 2021-01-12 DePuy Synthes Products, Inc. Intervertebral implant inserter and related methods
US10398563B2 (en) 2017-05-08 2019-09-03 Medos International Sarl Expandable cage
US11344424B2 (en) 2017-06-14 2022-05-31 Medos International Sarl Expandable intervertebral implant and related methods
US10940016B2 (en) 2017-07-05 2021-03-09 Medos International Sarl Expandable intervertebral fusion cage
US11446156B2 (en) 2018-10-25 2022-09-20 Medos International Sarl Expandable intervertebral implant, inserter instrument, and related methods
US11426286B2 (en) 2020-03-06 2022-08-30 Eit Emerging Implant Technologies Gmbh Expandable intervertebral implant
US11850160B2 (en) 2021-03-26 2023-12-26 Medos International Sarl Expandable lordotic intervertebral fusion cage
US11752009B2 (en) 2021-04-06 2023-09-12 Medos International Sarl Expandable intervertebral fusion cage
US12090064B2 (en) 2022-03-01 2024-09-17 Medos International Sarl Stabilization members for expandable intervertebral implants, and related systems and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276555B1 (it) * 1995-04-28 1997-11-03 Angeletti P Ist Richerche Bio Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni
IT1285790B1 (it) * 1996-09-24 1998-06-24 Angeletti P Ist Richerche Bio Adenovirus difettivi ricombinanti che codificano per mutanti di interleuchina 6 umana (hil-6) con attivita' antagonista o
GB9621095D0 (en) * 1996-10-09 1996-11-27 Imperial College Novel system
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation

Also Published As

Publication number Publication date
CA2400711A1 (en) 2001-09-13
DE60020269D1 (de) 2005-06-23
JP2003525906A (ja) 2003-09-02
PL356846A1 (en) 2004-07-12
AU2000233235A1 (en) 2001-09-17
KR100694005B1 (ko) 2007-03-12
US20050090443A1 (en) 2005-04-28
KR20020079984A (ko) 2002-10-21
EP1261367B1 (de) 2005-05-18
HUP0300117A3 (en) 2005-09-28
HUP0300117A2 (hu) 2003-04-28
DK1261367T3 (da) 2005-09-12
SK12412002A3 (sk) 2002-12-03
DE60020269T2 (de) 2006-01-19
EP1261367A1 (de) 2002-12-04
CZ20022760A3 (cs) 2003-03-12
US7160860B2 (en) 2007-01-09
ES2241583T3 (es) 2005-11-01
PT1261367E (pt) 2005-09-30
MXPA02008697A (es) 2003-04-14
WO2001066131A1 (en) 2001-09-13

Similar Documents

Publication Publication Date Title
DE60020269D1 (de) Verwendung von interleukin-6 antagonisten zur behandlung von oestrogen-abhängigen krebs
ATE453653T1 (de) Platinkomplexe zur behandlung von tumoren
DE602006014843D1 (de) Verwendung von hif 1alfa modulatoren zur behandlung von krebs
ATE323474T1 (de) Farnesyl protein transferase inhibitoren zur behandlung von brustkrebs
ATE313326T1 (de) VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß
ATE372341T1 (de) Inhibitoren von mitotischem kinesin
ATE337780T1 (de) Indoly-lsulphonyl-verbindungen zur behandlung von störungen des zns
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
PT1206474E (pt) Compostos de sulfonilfenilpirazole uteis como inibidores de cox-2
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
ATE428413T1 (de) Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
ATE346147T1 (de) Zusammensetzungen und methoden zur wundheilung
ATE222119T1 (de) Verwendung von erythropoietin zur behandlung von multiple myelom
ATE353667T1 (de) Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
DE602005007220D1 (de) Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs
ATE478076T1 (de) Azaxanthonen zur behandlung von tumoren
ATE445644T1 (de) Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten
DE60137721D1 (de) Inhibitoren von lyn-verbundener signaltransduktion (last) und deren verwendung zur behandlung von prostatakrebs
DE60123138D1 (de) Verwendung von progesteronrezeptorhemmern zur behandlung von steroid-resistentem brustkrebs
DE602005021681D1 (de) Stibogluconate-natrium und il-2 zur krebsbehandlung
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
DE60220825D1 (de) Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1261367

Country of ref document: EP

REN Ceased due to non-payment of the annual fee